SYNTERA BIORISK
SpeciesCattleReleaseNetherlands · 2026-09-07
  1. Global Overview
  2. Europe
  3. Netherlands
  4. Lumpy skin disease
Country–disease dossierNetherlands · Lumpy skin disease
View economic evidence Run scenarioCompare interventionsInspect BCR assumptions Vaccine & intervention marketTrade analysis
Decision lens · event frame

Netherlands · Lumpy skin disease

Official evidence remains visible. Unsupported intervention economics are withheld from the public decision view.

Official status · 2026-08-17The Netherlands remains described as LSD-free, while outbreaks in France and Italy create a material introduction risk requiring tighter transport hygiene.observed
Susceptible exposure · 2025 final3,643,796 headobserved
Published economicsUnavailableunavailable
Benefit-cost ratioBCR not estimatedILLUSTRATIVE
Economic evidence classes

Published, modelled, and private values remain separate

Published economic evidenceUnavailable

Direct outbreak loss · programme expenditure · compensation · trade loss. Unregistered components remain explicitly unavailable.

unavailable · source scope retained
Syntera modelled scenarioPreview ready

3,643,796 head · 5% affected · 140 EUR/head · 25m cost · 60% effectiveness.

Final outputs appear only after activation and run.
Client/private scenarioRestricted institutional workspace

Private prices, budgets, uptake, and client parameters are not stored in this public browser.

Request secure access
ILLUSTRATIVE

Illustrative scenario—country-specific intervention evidence unavailable.

The registered values are a transparent planning scenario, not a forecast or country-specific intervention estimate.

Open Impact CalculatorWhy these assumptions?
Inspect BCR calculation fingerprint
Input source
Registered susceptible exposure plus Syntera planning assumptions
Exposure
3,643,796 head · 2025 final
Affected share
5% · planning assumption
Loss per head
140 EUR · planning assumption
Programme cost
25m EUR · planning assumption
Effectiveness
60% · planning assumption
Time horizon
One event
Discount rate
0% · discounting not applied
Formula
potential loss = exposure × affected share × loss per affected head; avoided loss = potential loss × effectiveness; BCR = avoided loss ÷ programme cost
Evidence class
generic-syntera-planning-scenario · ILLUSTRATIVE
Limitations
Exploratory decision scenario, not an observed loss, budget, forecast or official effectiveness estimate. Defaults are editable Syntera planning assumptions.
Sources
NVWA · NVWA · Statistics Netherlands (CBS) · PDOK / Dutch Cadastre (Kadaster) · Government of the Netherlands
Assumptions and evidence

Registered basis

  • Official status is not silently converted into prevalence.
  • Province livestock exposure is observed CBS data, not a national allocation.
  • No UK or France economic coefficient or intervention effect is reused.
  • Planning-model defaults are editable Syntera assumptions, not observed Netherlands values.
Institutional service

Build a private BioRisk portfolio

Translate the public evidence architecture into a governed portfolio for your organisation, with private assumptions, operational thresholds and decision briefs kept separate from the public register.

About the founder
Institutional briefingDiscuss the decision contextCountry/disease stress testFrame an evidence-led exercisePrivate portfolioScope a governed deployment